Journal Article > ResearchFull Text
Confl Health. 1 December 2008; Volume 2 (Issue 1); DOI:10.1186/1752-1505-2-15
Reid AJ, van Engelgem I, Telfer B, Manzi M
Confl Health. 1 December 2008; Volume 2 (Issue 1); DOI:10.1186/1752-1505-2-15
ABSTRACT: Kenya's post-election violence in early 2008 created considerable problems for health services, and in particular, those providing HIV care. It was feared that the disruptions in services would lead to widespread treatment interruption. MSF had been working in the Kibera slum for 10 years and was providing antiretroviral therapy to 1800 patients when the violence broke out. MSF responded to the crisis in a number of ways and managed to keep HIV services going. Treatment interruption was less than expected, and MSF profited from a number of "lessons learned" that could be applied to similar contexts where a stable situation suddenly deteriorates.
Journal Article > ResearchFull Text
Trans R Soc Trop Med Hyg. 1 March 2008; Volume 102 (Issue 3); DOI:10.1016/j.trstmh.2007.12.007
Zachariah R, van Engelgem I, Massaquoi M, Kocholla L, Manzi M, et al.
Trans R Soc Trop Med Hyg. 1 March 2008; Volume 102 (Issue 3); DOI:10.1016/j.trstmh.2007.12.007
This retrospective analysis of routine programme data from Mbagathi District Hospital, Nairobi, Kenya shows the difference in rates of loss to follow-up between a cohort that paid 500 shillings/month (approximately US$7) for antiretroviral drugs (ART) and one that received medication free of charge. A total of 435 individuals (mean age 31.5 years, 65% female) was followed-up for 146 person-years: 265 were in the 'payment' cohort and 170 in the 'free' cohort. The incidence rate for loss to follow-up per 100 person-years was 47.2 and 20.5, respectively (adjusted hazard ratio 2.27, 95% CI 1.21-4.24, P=0.01). Overall risk reduction attributed to offering ART free of charge was 56.6% (95% CI 20.0-76.5). Five patients diluted their ART regimen to one tablet (instead of two tablets) twice daily in order to reduce the monthly cost of medication by half. All these patients were from the payment cohort. Payment for ART is associated with a significantly higher rate of loss to follow-up, as some patients might be unable to sustain payment over time. In resource-limited settings, ART should be offered free of charge in order to promote treatment compliance and prevent the emergence of drug resistance.
Journal Article > ResearchFull Text
AIDS Care. 1 February 2008; Volume 20 (Issue 2); DOI:10.1080/09540120701513677
Unge C, Johansson A, Zachariah R, Some D, van Engelgem I, et al.
AIDS Care. 1 February 2008; Volume 20 (Issue 2); DOI:10.1080/09540120701513677
The aim of this study was to explore why patients in the urban Kibera slum, Nairobi, Kenya, offered free antiretroviral treatment (ART) at the Médecins Sans Frontièrs (MSF) clinic, choose not to be treated despite signs of AIDS. Qualitative semi-structured interviews were conducted with 26 patients, 9 men and 17 women. Six main reasons emerged for not accepting ART: a) fear of taking medication on an empty stomach due to lack of food; b) fear that side-effects associated with ART would make one more ill; c) fear of disclosure and its possible negative repercussions; d) concern for continuity of treatment and care; e) conflicting information from religious leaders and community, and seeking alternative care (e.g. traditional medicine); f) illiteracy making patients unable to understand the information given by health workers.
Journal Article > CommentaryAbstract
Trans R Soc Trop Med Hyg. 1 August 2011; Volume 105 (Issue 8); DOI:10.1016/j.trstmh.2011.04.014
Zachariah R, Tayler-Smith K, Manzi M, Massaquoi M, Mwagomba B, et al.
Trans R Soc Trop Med Hyg. 1 August 2011; Volume 105 (Issue 8); DOI:10.1016/j.trstmh.2011.04.014
Among adults eligible for antiretroviral therapy (ART) in Thyolo (rural Malawi) and Kibera (Nairobi, Kenya), this study (a) reports on retention and attrition during the preparation phase and after starting ART and (b) identifies risk factors associated with attrition. 'Retention' implies being alive and on follow-up, whilst 'attrition' implies loss to follow-up, death or stopping treatment (if on ART). There were 11,309 ART-eligible patients from Malawi and 3633 from Kenya, of whom 8421 (74%) and 2792 (77%), respectively, went through the preparation phase and started ART. In Malawi, 2649 patients (23%) were lost to attrition in the preparation phase and 2189 (26%) after starting ART. Similarly, in Kenya 546 patients (15%) were lost to attrition in the ART preparation phase and 647 (23%) while on ART. Overall programme attrition was 43% (4838/11,309) for Malawi and 33% (1193/3633) for Kenya. Restricting cohort evaluation to 'on ART' (as is usually done) underestimates overall programme attrition by 38% in Malawi and 36% in Kenya. Risk factors associated with attrition in the preparation phase included male sex, age <35 years, advanced HIV/AIDS disease and increasing malnutrition. Considerable attrition occurs during the preparation phase of ART, and programme evaluations confined to on-treatment analysis significantly underestimate attrition. This has important operational implications, which are discussed here.